Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ISTH 2023 | Exigency sub-study: supporting patients with hemophilia when gene therapy is not an option

Simon Fletcher • 26 Jun 2023
ISTH 2023
Hemophilia Non-Malignant

In this video, Simon Fletcher, MA, BA (Hons), Dip N, RGN , Haemnet / Oxford University Hospitals NHS Foundation Trust, Oxford, UK, briefly discusses the challenges of approaching patients with hemophilia who are unable to undergo gene therapy, emphasizing the importance of providing psychological support throughout the entire process. This interview took place at the 31st Congress of the International Society on Thrombosis and Haemostasis (ISTH), held in Montréal, Canada.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Simon Fletcher

1:36
Exigency study: exploring the impact of steroids following gene therapy for hemophilia
Simon Fletcher • 26 Jun 2023

Related Videos

2:34
A national physician survey investigating the management of pulmonary thromboembolism in pregnancy
Giulia Simini • 29 Apr 2024
1:39
Considering the use of gene therapy in severe inherited thrombophilia
Beverley Hunt • 29 Apr 2024
3:11
The therapeutic implications of shared pathophysiology in classical ITP and other thrombocytopenias
Simona Pagliuca • 24 Apr 2024
2:01
The MDT in the new era of gene therapy for hemoglobinopathies
Mattia Algeri • 15 Apr 2024
The content of VJHemOnc is intended for healthcare professionals